Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stockwatch: Earnings Move From Mediocre to Worse

Executive Summary

There is now no sugar-coating of the first-quarter 2016 earnings season for life sciences companies. By the end of the previous week a few companies had reported results that didn't disappoint but also didn't blow off any socks. By contrast, the second full week of earnings reports majored in significant disappointment.


Related Content

Stockwatch: What Links Actimmune And Vertex’s Event Horizon?
Q1 Earnings In Brief: Celgene, Alkermes, Novo Nordisk, Acorda, Alexion
Amgen Earnings Beat Expectations; Company Pushing Payers On Repatha
Gilead Not Bullet-Proof After All: Harvoni US Sales Tumble More Than 50%
Data Trumps Anecdotes, Emotion At Sarepta Panel


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts